Georgia Retina Completes Phase III Clinical Trial on Drug for Diabetic Macular Edema
Posted by: Georgia Retina in Uncategorized
Patients in Clinical Trial Showed Improvements In their Vision after 24 Months Georgia Retina, the state’s largest retina-only private practice, joins drug manufacturer Genentech in announcing the successful completion of a Phase III clinical trial on a drug to treat patients with diabetic macular edema (DME). Dr. Mark J. Rivellese, the principal investigator at Georgia…
Read More